Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial. - Reardon, David A.; Kim, Tae Min; Frenel, Jean‐Sebastien; Simonelli, Matteo; Lopez, Juanita; Subramaniam, Deepa S.; Siu, Lillian L.; Wang, Hui; Krishnan, Suba; Stein, Karen; Massard, Christophe (Cancer (0008543X), 2021)